Literature DB >> 26076319

Olfactory identification and its relationship to executive functions, memory, and disability one year after severe traumatic brain injury.

Solrun Sigurdardottir1, Nada Andelic2, Toril Skandsen3, Audny Anke4, Cecilie Roe5, Oyvor Oistensen Holthe5, Eike Wehling6.   

Abstract

OBJECTIVE: To explore the frequency of posttraumatic olfactory (dys)function 1 year after severe traumatic brain injury (TBI) and determine whether there is a relationship between olfactory identification and neuropsychological test performance, injury severity and TBI-related disability.
METHOD: A population-based multicenter study including 129 individuals with severe TBI (99 males; 16 to 85 years of age) that could accomplish neuropsychological examinations. Olfactory (dys)function (anosmia, hyposmia, normosmia) was assessed by the University of Pennsylvania Smell Identification Test (UPSIT) or the Brief Smell Identification Test (B-SIT). Three tests of the Delis-Kaplan Executive Function System (D-KEFS) were used to assess processing speed, verbal fluency, inhibition and set-shifting, and the California Verbal Learning Test-II was used to examine verbal memory. The Glasgow Outcome Scale-Extended (GOSE) was used to measure disability level.
RESULTS: Employing 2 different smell tests in 2 equal-sized subsamples, the UPSIT sample (n = 65) classified 34% with anosmia and 52% with hyposmia, while the B-SIT sample (n = 64) classified 20% with anosmia and 9% with hyposmia. Individuals classified with anosmia by the B-SIT showed significantly lower scores for set-shifting, category switching fluency and delayed verbal memory compared to hyposmia and normosmia groups. Only the B-SIT scores were significantly correlated with neuropsychological performance and GOSE scores. Brain injury severity (Rotterdam CT score) and subarachnoid hemorrhage were related to anosmia. Individuals classified with anosmia demonstrated similar disability as those with hyposmia/normosmia.
CONCLUSIONS: Different measures of olfaction may yield different estimates of anosmia. Nevertheless, around 1 third of individuals with severe TBI suffered from anosmia, which may also indicate poorer cognitive outcome. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 26076319     DOI: 10.1037/neu0000206

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  6 in total

1.  Olfactory Function and Associated Clinical Correlates in Former National Football League Players.

Authors:  Michael L Alosco; Johnny Jarnagin; Yorghos Tripodis; Michael Platt; Brett Martin; Christine E Chaisson; Christine M Baugh; Nathan G Fritts; Robert C Cantu; Robert A Stern
Journal:  J Neurotrauma       Date:  2016-08-11       Impact factor: 5.269

2.  Contrasting olfaction, vision, and audition as predictors of cognitive change and impairment in non-demented older adults.

Authors:  Stuart W S MacDonald; Connor J C Keller; Paul W H Brewster; Roger A Dixon
Journal:  Neuropsychology       Date:  2018-05       Impact factor: 3.295

3.  Olfaction and Executive Cognitive Performance: A Systematic Review.

Authors:  Vasudeva Murthy Challakere Ramaswamy; Peter William Schofield
Journal:  Front Psychol       Date:  2022-05-09

4.  A Latent Content Analysis of Barriers and Supports to Healthcare: Perspectives From Caregivers of Service Members and Veterans With Military-Related Traumatic Brain Injury.

Authors:  Noelle E Carlozzi; Rael T Lange; Louis M French; Angelle M Sander; Jenna Freedman; Tracey A Brickell
Journal:  J Head Trauma Rehabil       Date:  2018 Sep/Oct       Impact factor: 2.710

5.  Validation of the NIH Toolbox in Individuals with Neurologic Disorders.

Authors:  N E Carlozzi; S Goodnight; K B Casaletto; A Goldsmith; R K Heaton; A W K Wong; C M Baum; R Gershon; A W Heinemann; D S Tulsky
Journal:  Arch Clin Neuropsychol       Date:  2017-08-01       Impact factor: 2.813

6.  Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study.

Authors:  Pietro De Luca; Angelo Camaioni; Pasquale Marra; Giovanni Salzano; Giovanni Carriere; Luca Ricciardi; Resi Pucci; Nicola Montemurro; Michael J Brenner; Arianna Di Stadio
Journal:  Cells       Date:  2022-08-17       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.